https://www.selleckchem.com/products/pk11007.html
Significant improvement in right answers was obtained for three questions "nuchal translucency is included in the combined screening test for DS" (p = 0,007); "blood serum markers is included in the combined screening for DS" (p = 0,009) and advanced maternal age increases risk for DS" (p = 0,004). Total score in the post questionnaire was significantly higher than the "pre" consultation questionnaire (14,7 ± 2.8 versus 14,1 ± 2.9; p = 0.01). Patients show a high level of knowledge on screening strategies for DS in pre-consultation. The